Abstract
The primary route of entry into the body for many viruses, including herpes simplex virus type 2 (HSV-2) and the influenza virus, is via mucosal surfaces. It follows that, depending on the numbers of virions deposited on such surfaces, their infectious quality and distribution over the mucosal surface, the existence or early mobilisation of specific defence mechanisms at the time of this contact, supplementing or enhancing any non-specific resistance mechanisms already operating at these sites may tip the balance in favour of the host and result in elimination of the invading virus before it can become established in the tissues and produce disease symptoms.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Asanuma, H., Koide, F., Suzuki, Y., Nagamine, T., Aizawa, C., Kurata, T and Tamura, S., 1995, Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration. Vaccine, 13, 3.
Barr, I.G. and Mitchell, G.F., 1996, ISCOMs (immunostimulating complexes): The first decade. Immunology and Cell Biology, 74, 8.
Ben-Ahmeida, E.T.S., Jennings, R., Erturk, M. and Potter, C.W., 1992, The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMs, with FCA, ALH or as infectious virus. Archives of Virology, 125, 71.
Ben-Ahmeida, E.T.S., Gregoriadis, G., Potter, C.W. and Jennings, R., 1993, Immuno-potentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice. Vaccine, 11, 1302.
Bowen, J.C., Alpar, H.O., Phillpotts, R. and Brown, M.R.W., 1992, Mucosal delivery of herpes simplex virus vaccine. Research in Virology, 143, 269.
Byars, N.E., Fraser-Smith, E.B., Pecyk, R.A., 1994, Vaccinating guinea-pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection. Vaccine, 12, 200.
de Haan, A., Renegar, K.B., Small, P.A. Jr. and Wilschutt, J., 1995, Induction of a secretory IgA response in the murine female urogenital tract by immunisation of the lungs with liposome-supplemented viral subunit antigen. Vaccine, 13, 613.
Eis-Hubinger, A.M., Schmidt, D.S. and Schneweis, K.E., 1993, Anti-glycoprotein B mono-clonal antibody protects T-cell depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. Journal of General Virology, 74, 379–385.
Erturk, M., Jennings, R., Hockley, D. and Potter, C.W., 1989, Antibody responses and protection in mice immunised with herpes simplex type 1 antigen immune-stimulating complex preparations. Journal of General Virology, 70, 2149.
Erturk, M., Jennings, R., Philipotts, R.J. and Potter, C.W., 1991, Biochemical characterisation of herpes simplex type 1 immunostimulating complexes (ISCOMs): A multiglyco-protein structure. Vaccine, 9, 668.
Erturk, M., Philipotts, R.J. Welch, M.J. and Jennings, R., 1991, Efficacy of HSV-ISCOM vaccine in the guinea-pig model of HSV-2 infection. Vaccine, 9, 728.
Erturk, M., Hill, T.J., Shimeld, C. and Jennings, R., 1992, Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine. Archives of Virology, 125, 87.
Farag, I.F., Phili, R.W., Rosborough, J.P. and Six, H.R., 1988, Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine, 6, 262.
Farrell, H., McLean, C.S., Harley, C., Efstathiou, S., Inglis, S.C. and Minson, A.C., 1994, Vaccine potential of a herpes simplex virus type 1 mutant with an essential glyco-protein deleted. Journal of Virology, 68, 927.
Galuchan, W.S. and Rosenthal, K.L., 1995, Specific secretory immune responses in the female genital tract following intranasal immunisation with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine, 13, 1589.
Gallichan, W.S. and Rosenthal, K.L., 1996, Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunisation. Journal of Experimental Medicine, 184, 1879.
Ghazi, H.O., Potter, C.W., Smith, T.L. and Jennings, R., 1995a, Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs. Journal of Medical Microbiology, 42, 53.
Ghazi, H.O., Erturk, M., Stannard, L.M., Faulkner, M., Potter, C.W. and Jennings, R., 1995b, Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice. Archives of Virology, 140, 1015.
Hassan, Y., Brewer, J.M., Alexander, J. and Jennings, R., 1996, Immune responses in mice induced by HSV-1 glycoprotein presented with ISCOMs or NISV delivery systems. Vaccine, In press.
Hazama, M., Mayumi-Aono, A., Miyazaki, T., Hinuma, S. and Fujisawa, Y., 1993, Intranasal immunisation against herpes simplex virus infection by using a recombinant glyco-protein D fused with immuno-modulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology, 78, 643.
Jones, P.D., Tha-Hla, R., Morein, B., Lovgren, K. and Ada, G.L., 1988, Cellular immune responses in the murine lung to local immunisation with influenza A virus glyco-proteins in micelles and immuno-stimulatory complexes. Scandinavian Journal of Immunology, 27, 645.
McBride, B.W., Ridgeway, P., Philipotts, R. and Newell, D.G., 1988, Mucosal antibody response to vaginal infection with herpes simplex virus in pre-vaccinated guinea-pigs. Vaccine, 6, 414.
McDermott, M.R., Brais, L.J and Evelegh, M.J., 1990, Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. Journal of General Virology, 71, 1497.
McGhee, J.R. and Kiyono, H., 1993, New perspectives in vaccine development: Mucosal immunity to infections. Infectious Agents and Disease, 2, 55.
McLean, C.S., Erturk, M., Jennings, R., Ni Challanain, D., Minson, A.C., Duncan, I. Bournsell, M.E.G. and Inglis, S.C., 1994, Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. Journal of Infectious Diseases, 170, 100.
McLean, C.S., Ni Challanain, D., Duncan, I., Bournsell, M.E.G., Jennings, R. and Inglis, S.C., 1996, Induction of a protective immune response by mucosal immunisation with a DISC HSV-1 vaccine. Vaccine, 14, 987.
Meitin, C.A., Bender, B.S. and Small, P.A. Jr., 1991, Influenza immunisation: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine. Vaccine, 9, 751.
Moldoveanu, Z., Novak, M., Huang, W-Q, Gilley, R.M., Staas, J.K., Schafer, D., Compans, R.W. and Mestecky, J., 1993, Oral immunisation with influenza virus in biodegradable microspheres. Journal of Infectious Diseases, 167, 84.
Moldoveanu, Z., Clements, M.L., Prince, S.J., Murphy, B.R. and Mestecky, J., 1995, Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine, 13, 1006.
Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. and Osterhaus, A., 1984, ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature, 308, 457.
Mowat, A. McI., 1987, The regulation of immune responses to dietary protein antigens. Immunology Today. 8, 93.
Mowat, A.McI., Donachie, A.M., Reid, G. and Jarrett, O., 1991, Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology, 72, 317.
Mowat, A.McI., Maloy, K.J. and Donachie, A.M., 1993, Immune stimulating complexes (ISCOMs) are unique adjuvants for oral immunisation with protein antigens. Immunology, 80, 661.
Offit, P.A. and Dudzik, K.I., 1989, Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. Journal of Virology, 63, 3507.
Pang, G.T., Clancy, R.L., O’Reilly, S.E. and Cripps, A.W., 1992, A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunisation. Journal of Virology, 66, 1162.
Renegar, K.B. and Small, P.A. Jr., 1991, Passive transfer of local immunity to influenza virus infections by IgA antibody. Journal of Immunology, 146, 1972.
Roitt, I., Brostoff, J. and Male, D., eds., 1996, Vaccination, In: “Immunology”, Chapter 19; p. 191. 4th Edition, Published by Mosby.
Thapar, M.A., Parr, E.L. and Parr, M.B., 1990, The effect of adjuvants on antibody titres in mouse vaginal fluid after intravaginal immunisation. Journal of Reproductive Immunology, 17, 207.
Thornton, B., Baskerville, A., Bailey, N.E., Melling, J.M. and Hambleton, P., 1984, Herpes simplex virus genital infection of the female guinea-pig as a model for evaluation of an experimental vaccine. Vaccine, 2, 141.
Walker, R.L., 1994, New strategies for using mucosal vaccination to achieve more effective immunisation. Vaccine, 12, 387.
Whaley, K.J., Zeitlin, L., Barratt, R.A., Hoen, T.E. and Cone, R.A., 1994, Passive immunisation of the vagina protects mice against vaginal transmission of genital herpes infections. Journal of Infectious Diseases, 169, 647.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jennings, R., Challanáin, D.N., Ghazi, H.O., McLean, C.S. (1997). Vaccines and Vaccine Delivery Systems: Experience with HSV, Influenza and Mucosal Routes of Immunisation. In: Gregoriadis, G., McCormack, B., Allison, A.C. (eds) Vaccine Design. NATO ASI Series, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0062-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0062-3_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0064-7
Online ISBN: 978-1-4899-0062-3
eBook Packages: Springer Book Archive